Novel 6-substituted-2-morpholino-8-(1-(arylamino or aryloxo)ethyl)-4H-benzo[e][1,3]oxazin-4-ones as Selective PI3K Inhibitors and Anticancer Compounds

Mohammed, Ehtesham

doi:10.26181/17304002.v1

Thesis.pdf (2.51 MB)

Download file

Novel 6-substituted-2-morpholino-8-(1-(arylamino or aryloxo)ethyl)-4H-benzo[e][1,3]oxazin-4-ones as Selective PI3K Inhibitors and Anticancer Compounds

thesis

posted on 2021-12-21, 01:10 authored by Ehtesham MohammedEhtesham Mohammed

A thesis submitted in total fulfilment of the requirements for the degree of Doctor of Philosophy to the Department of Pharmacy and Biomedical Sciences, School of Molecular Sciences, College of Science, Health and Engineering, La Trobe University, Victoria, Australia.

History

School

School of Molecular Sciences

Center or Department

Department of Pharmacy and Biomedical Sciences

Thesis type

Ph. D.

Awarding institution

La Trobe University

Year Awarded

2021

Rights Statement

This thesis contains third party copyright material which has been reproduced here with permission. Any further use requires permission of the copyright owner. The thesis author retains all proprietary rights (such as copyright and patent rights) over all other content of this thesis, and has granted La Trobe University permission to reproduce and communicate this version of the thesis. The author has declared that any third party copyright material contained within the thesis made available here is reproduced and communicated with permission. If you believe that any material has been made available without permission of the copyright owner please contact us with the details.